AgomAb Therapeutics NV American Depositary Shares
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -17,623 | -18,047 |
EBIT | -17,540 | -18,154 |
Net Income | -17,401 | -18,278 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -13,175 | -13,638 |
Cash | 86,418 | 129,585 |
Basic Shares | 48,736 | 42,486 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -210 | |||
EBITDA | -62,268 | -45,885 | -11,879 | -10,738 |
EBIT | -62,487 | -46,196 | -11,978 | -10,761 |
Net Income | -62,547 | -46,267 | -11,390 | -8,142 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -51,745 | -47,503 | -24,592 | -18,967 |
Cash | 86,418 | 171,459 | 122,402 | 27,670 |
Basic Shares | 48,736 | 36,236 | 36,236 | 36,236 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.41 |